FDA Label for Aronamin Gold

View Indications, Usage & Precautions

Aronamin Gold Product Label

The following document was submitted to the FDA by the labeler of this product Oasis Trading. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Otc - Purpose



Vitamines, Mineral & nutrients


Otc - Keep Out Of Reach Of Children



Keep out of reach of children


Indications & Usage



Adults: take 1 tablet twice a day.


Warnings



1) Do not take this medicine.

(1) Patients with hypersensitivity reactions to NSAIDs and the components contained in NSAIDs

(2) Infants under three months of age

(3) Because this drug contains lactose, patients with genetic problems such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption Do not administer.

2) Do not take the following medicine while taking this medicine.

(1) levodopa

3) Consult a doctor, dentist or pharmacist before taking this medicine.

(1) Patients receiving medical treatment

(2) patients with hyperoxaluria (excessive urinary excretion of urine)

(3) Pregnant women and possibly pregnant women, lactating women, premature infants, infants

(4) Patients with gout or kidney stones

4) Stop taking this drug immediately and consult a doctor, dentist, or pharmacist if you: Whenever possible, bring this attached document with you.

(1) If you have any of the following symptoms

Stomach discomfort, diarrhea, constipation, rash, fever, nausea, vomiting, dilated stool, stomatitis (mouth salt), anorexia, abdominal bloating

(2) Administration of this drug may result in faster or more frequent menstruation, and bleeding may last for a long time.

(3) The risk of thrombosis may be increased if a woman taking an oral contraceptive containing estrogen or a patient with thrombotic placenta is taking vitamin E.

(4) Long-term administration of high doses may result in resistance.

(5) Prolonged use of pyridoxine at a dose of 500 mg to 2 g / day may result in neuropathy or neuropathy (functional disorder or pathologic changes) in the peripheral nervous system.

(6) Hematologic adverse events may occur when vitamin B12 is administered at a dose of 10 μg or more per day in patients with insufficient folic acid.

5) Other Precautions for Taking

(1) Keep the prescribed dosage and dosage.

(2) it may interfere with the detection of blood glucose during various urine tests

(3) The urine may turn yellow, which may affect the clinical examination

6) Storage Precautions

(1) Keep out of the reach of children.

(2) Avoid direct sunlight. Store in a cool, dry place.

(3) To prevent misuse (misuse) and to preserve quality, please do not put in another container.


Inactive Ingredient



Microcrystalline Cellulose, Magnesium Stearate, Crospovidone, Copovidone, Colloidal Silicon Dioxide, OY-25014, OY-S-29019


Dosage & Administration



For oral use only


* Please review the disclaimer below.